BRAF and cutaneous mastocytosis: BRAF mutation burden (p = 0.001- post estimation by Pearson χ2 goodness-of-fit test p = 0.4) depended significantly on age at diagnosis (p = 0.001) and in borderline significance on the anatomical site where CM developed (p = 0.05).